# News

## [PolarisQB Demonstrates Advances in Drug Safety Prediction with Quantum-Inspired AI, Enabling Earlier Elimination of Toxic Compounds from Discovery Pipeline](https://polarisqb.com/polaris-news/polarisqb-demonstrates-advances-in-drug-safety-prediction-with-quantum-inspired-ai-enabling-earlier-elimination-of-toxic-compounds-from-discovery-pipeline/)

PolarisQB advances drug safety prediction with quantum-inspired AI, enabling early removal.

## [Polaris Quantum Biotech has been selected as a 2026 winner of the Cleveland Clinic Quantum Innovation Catalyzer Program](https://polarisqb.com/polaris-news/polaris-quantum-biotech-has-been-selected-as-a-2026-winner-of-the-cleveland-clinic-quantum-innovation-catalyzer-program/)

DURHAM, NC - Polaris Quantum Biotech has been selected as a.

## [PolarisQB Published A Manuscript Demonstrating The Superiority Of Quantum Computing Over AI In Drug Design](https://polarisqb.com/polaris-news/polarisqb-published-a-manuscript-demonstrating-the-superiority-of-quantum-computing-over-ai-in-drug-design/)

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in.

## [PolarisQB Receives DARPA EEI Award to Advance Quantum Computing for Drug Design](https://polarisqb.com/polaris-news/polarisqb-receives-darpa-eei-award-to-advance-quantum-computing-for-drug-design/)

DURHAM, NC - The Defense Advanced Research Projects Agency (DARPA).

## [Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform – Beta Testers Wanted](https://polarisqb.com/polaris-news/polarisqb-unveils-quadd-nextgen-quantum-ai-drug-discovery-platform/)

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in.

## [An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site](https://polarisqb.com/polaris-news/an-investigation-of-allostery-in-epidermal-growth-factor-receptor-using-sextant-with-dynamics-simulations-to-expand-an-apo-site/)

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

## [Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats](https://polarisqb.com/polaris-news/quantum-aided-drug-design-for-inhibiting-protein-protein-interactions-for-emerging-threats/)

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to.

## [Hybrid Quantum Approach for Sampling Molecular Fragment Libraries to Discover Novel Therapeutics for Ebola](https://polarisqb.com/polaris-news/hybrid-quantum-approach-for-sampling-molecular-fragment-libraries/)

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify.

## [Sextant: A New Tool for Designing Custom Molecular Templates for Protein-Protein Interaction Inhibitor Drug Design](https://polarisqb.com/polaris-news/sextant-a-new-tool-for-designing-custom-molecular-templates-for-protein-protein-interaction-inhibitor-drug-design/)

Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is.

## [Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets](https://polarisqb.com/polaris-news/quadd-webinar-find-your-star-molecule-2/)

On Tuesday, October 1, PolarisQB hosted a webinar titled "Find.

## [PolarisQB Joins OpenFold AI Consortium along with Congruence, Biogen, Psivant and Others](https://polarisqb.com/polaris-news/polarisqb-joins-openfold-ai-consortium-along-with-congruence-biogen-psivant-and-others/)

OpenFold, a leading non-profit artificial intelligence (AI) research consortium focused on.

## [Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design](https://polarisqb.com/polaris-news/integration-of-virtual-libraries-from-liverpool-chirochem-into-quantum-aided-drug-design/)

PolarisQB is happy to announce the integration of Virtual Libraries and.

## [QuADD Webinar: Delivering Business Value with Quantum-Aided Drug Design](https://polarisqb.com/polaris-news/quadd-webinar-delivering-business-value-with-quantum-aided-drug-design/)

Quantum-Aided Drug Design (QuADD) is delivering value to our customers.

## [QuADD Webinar: Find Your Star Molecule](https://polarisqb.com/polaris-news/quadd-webinar-find-your-star-molecule/)

On Friday, May 17, PolarisQB hosted a group of thought.

## [PolarisQB Announces the Addition of Board Member Anat Naschitz](https://polarisqb.com/polaris-news/polarisqb-announces-the-addition-of-board-member-anat-naschitz/)

POLARISqb, a company revolutionizing drug design by joining quantum computing.

## [PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform](https://polarisqb.com/polaris-news/polarisqb-and-scientist-com-partner/)

POLARISqb, the first company to build quantum-enabled molecular optimization tools.

## [Quantum-Aided Drug Design from POLARISqb Demonstrates Best-in-Class Capabilities](https://polarisqb.com/polaris-news/quadd-best-in-class/)

Polaris Quantum Biotech (PolarisQB), the leader in quantum computing-based drug.

## [PolarisQB Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design](https://polarisqb.com/polaris-news/polarisqb-receives-darpa-impaqt-funding-to-advance-quantum-computing-for-drug-design/)

The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a.

## [PolarisQB and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service](https://polarisqb.com/polaris-news/polarisqb-and-syntekabio-sign-mou-for-collaborative-ai-and-quantum-powered-drug-development-service/)

PolarisQB, the first company in the world to develop a drug.

## [PolarisQB New SaaS, Quantum-Aided Drug Design (QuADD) Demonstrates Advantage Versus Traditional Library Builds](https://polarisqb.com/polaris-news/polarisqb-new-saas-quantum-aided-drug-design-quadd-demonstrates-advantage-versus-traditional-library-builds/)

At Polaris Quantum Biotech, we’re leveraging quantum computing to accelerate drug discovery.